Lifeboat Foundation

“Yep, transforming health care and telepathy, those are the items on her to-do list. Jepsen plans to achieve both goals with a cheap wearable device that her engineers are now tinkering with in the lab. And then there’s the side benefit of reinvigorating the tired consumer electronics industry, which Jepsen thinks is due for the next big thing.

Jepsen was at SXSW to give a talk about Openwater, her new startup. While the company is still conducting R&D to decide on its first products, Jepsen feels the need to speak out now about what she’s building and how she thinks her technology could radically change society. She wants to give people fair warning and time to think about what’s coming. “I know it seems outlandish to be talking about telepathy, but it’s completely solid physics and mathematical principles—it’s in reach in the next three years,” she says.

Plus, she’s sick of stealth mode. “I haven’t been able to to talk about what I’ve been doing for five and half years while I was at Google and Facebook, and I don’t think secrecy is useful,” she says. She left Facebook in August, and in September she filed patents for her Openwater technology, which she expects to be issued any day now.

Continue reading “Why Mary Lou Jepsen Left Facebook: To Transform Health Care and Invent Consumer Telepathy” »

https://www.instagram.com/uberfacts/

JUDY WOODRUFF: For decades, researchers have worked to create a better and more direct connection between a human brain and a computer to improve the lives of people who are paralyzed or have severe limb weakness from diseases like ALS.

Those advances have been notable, but now the work is yielding groundbreaking results.

Special correspondent Cat Wise has the story.

Continue reading “Typing sentences by simply thinking is possible with new technology” »

New studies from NYU and John Hopkins University show the effectiveness of psilocybin in treating depression and anxiety of cancer patients.

When you’re in a daydream, or “alpha,” state, your brainwaves are oscillating at a rate of 8 to 12 Hz.

Steven Kotler explains what happens in your brain at aha moments.

Tech big shots are charging into neuroscience, but do they even have a clue?

George Church is very interested in your memories now.

Harvard researcher George Church is looking for people with exceptionally good memory to take part in a study aimed at finding genetic mechanisms that boost memory in research that could one day result in better drugs or diagnostic tests.

Church and other researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School’s Personal Genome Project, in collaboration with Lumos Labs — the makers of the brain-training game Lumosity — will look for common genetic markers in individuals with exceptional memories, attention and reaction speeds.

Continue reading “George Church, Lumosity want those with good memory to ‘share it, not hoard it’” »

Coffee turns up some interesting properties and it isnt the caffeine in that is the star of the show.

Could coffee be a geroprotector?

Continue reading “A major neuroprotective component in coffee” »

A team of engineers at the University of California San Diego and La Jolla-based startup Nanovision Biosciences Inc. have developed the nanotechnology and wireless electronics for a new type of retinal prosthesis that brings research a step closer to restoring the ability of neurons in the retina to respond to light. The researchers demonstrated this response to light in a rat retina interfacing with a prototype of the device in vitro.

They detail their work in a recent issue of the Journal of Neural Engineering. The technology could help tens of millions of people worldwide suffering from neurodegenerative diseases that affect eyesight, including macular degeneration, retinitis pigmentosa and loss of vision due to diabetes.

Despite tremendous advances in the development of retinal prostheses over the past two decades, the performance of devices currently on the market to help the blind regain functional vision is still severely limited—well under the acuity threshold of 20/200 that defines legal blindness.